Immunoglobulin A (IgA) and IgG antibodies against Streptococcus mutans KlR and 10449 were measured in serum and in stimulated whole saliva from two groups of naval recruits, representing high or low caries susceptibility. The antibody assays were performed by using the enzyme-linked immunosorbent assay, and the results were expressed by a method able to estimate the amount of high-avidity and total specific antibodies. As a control, concentrations of salivary total immunoglobulins were related to the amounts of specific antibodies. Further, antibodies were assayed against three antigens, unrelated to the streptococci. No clear differences were observed in serum antibodies between the subjects with high or low caries susceptibility. However, in saliva, low caries susceptibility was associated with a high amount of total antigen-specific IgA, and possibly IgG, against S. mutans. This difference between the groups still existed when the amounts of specific antibodies were related to the amounts of salivary immunoglobulins. There were no differences in the amounts of total specific antibodies against the unrelated antigens. No differences were observed in the estimates of high-avidity anti-S. mutans antibodies between the groups, either in serum or saliva. Thus, within the limitations of the assays and crude antigen, lack of high-avidity antibodies is not responsible for caries susceptibility. Instead, the amount of anti-S. mutans antibodies seems to be linked with caries protection. The results of the present study indicate that salivary antibodies are linked with the control of human dental caries.
Streptococcus mutans is a major etiological agent in human dental caries. Specific antibodies against this bacterium are found in serum and saliva (6) . Salivary antibodies originate either from salivary glands (3) or from serum antibodies via crevicular fluid (4) . Local gingival immunoglobulin synthesis also occurs, at least when gingival inflammation is involved (2) . The exact role of these antibodies in the control of dental caries is still unclear despite being intensively studied.
Low-caries experience in humans is associated with high levels of serum antibodies against S. mutans (5) (6) (7) 16 ). In immunization experiments with primates, a rise in serum immunoglobulin G (IgG) antibodies against S. mutans protein antigen is associated with caries protection (22, 23) .
Salivary antibodies, in contrast to serum antibodies, are not so clearly shown to be protective. In rodents, salivary antibodies against S. mutans antigens protect against caries (27, 29, 33) . In immunization experiments with primates, IgA antibodies against S. mutans were associated with a reduction of the amount of the bacterium in the oral cavity (10) , but this protective response has invariably not been recorded (8) . A negative correlation between salivary IgA antibodies against S. mutans and caries index has been found in children (12) , but in several studies with adults, no cariesreducing effect of salivary antibodies has been detected (4, 5, 15) . Further, there is even some evidence that salivary IgA against S. mutans is caries enhancing (7) . In humans, indirect evidence of the protective role of salivary IgA antibodies has been obtained in patients with IgA deficiency (18) . The differing results of the previous studies may be due to the fact that the measurement of salivary antibodies is difficult to standardize because of differing flow rates (14, 30) * Corresponding author.
and considerable day-to-day variation of individual salivary immunoglobulin concentrations (13) .
In this study, anti-S. mutans antibodies of IgA and IgG classes in serum and stimulated whole saliva were measured in subjects with high-or low-caries susceptibility. Antibody avidity may have a role in protection against caries (19, 20, 31) . Therefore, in this study, a modified enzyme-linked immunosorbent assay (ELISA) was employed, enabling us to perform independent estimations of high-avidity and total antigen-specific antibodies (25, 26) . In addition, salivary and serum total IgA and IgG were assayed. To evaluate the validity of anti-S. mutans antibodies, three unrelated antigens were also used in the antibody assays.
MATERIALS AND METHODS Subjects. The dental status of 290 recruits serving at Turku Naval Base was examined to find two different groups representing high or low caries susceptibility. The highcaries-susceptibility group (HCS group), consisted of 12 subjects with a high decayed, missing, or filled tooth index (mean + standard deviation, 21.4 ± 5.8) and numerous dentine carious lesions (7.1 + 5.7). Furthermore, paraffinstimulated whole saliva samples from all HCS subjects yielded 2105 CFU of aciduric bacteria per ml as determined with the Dentocult dip-slide test (Orion Diagnostica, Espoo, Finland) (17) . The 12 subjects of the low-caries-susceptibility group (LCS group) had a low decayed, missing, or filled tooth index (6.8 ± 2.4), no present dentine caries, and i104 CFU of aciduric bacteria in their saliva. Visible plaque (1) was encountered in 7.2 ± 6.4 and 2.6 ± 3.2 teeth in the HCS group and the LCS group, respectively. Gingival bleeding indices (1) were 7.3 ± 5.5 and 3.1 + 3.0, correspondingly. The flow rate of paraffin-stimulated saliva was 1.3 + 0.4 ml/min in the HCS group and 1.8 ± 0.5 ml/min in the LCS S. MUTANS ANTIBODIES AND DENTAL CARIES 309 group. All of the subjects were 18 to 22 years of age and had been recently vaccinated against tetanus and parotitis. All of the subjects had received pertussis vaccination in their childhood.
Saliva and blood samples. Whole saliva samples were collected between 9 and 11 a.m., at least 2 h after the last meal, in a quiet room. The subjects chewed a 5-g piece of paraffin wax. The saliva secreted within the first 30 s was swallowed and saliva was collected for the next 5 min. The saliva was immediately frozen and transported to the laboratory. The saliva was inactivated by heating at 56°C for 30 min, centrifuged at 1,000 x g for 30 min, and stored at -700C.
Venous blood was drawn for serum samples after the collection of the saliva. The sera were stored at -200C.
Assay of total IgA and IgG in whole saliva. The total amount of IgA and IgG in saliva was assayed by using a "trapping antibody"-type enzyme immunoassay. For IgA measurement, polystyrene microtiter plates (Linbro; Flow Laboratories, Inc., McLean, Va.) were coated by adding 75 ,ul of rabbit anti-human IgA (Dako-Immunoglobulins a/s, Copenhagen, Denmark) diluted 1:500 in bicarbonate buffer (pH 9.6) and incubated overnight at room temperature. The plates were washed twice by adding 0.9% NaCI containing 0.05% Tween 20 (NaCI-Tween) and once with phosphatebuffered saline (PBS), pH 7.4. The plates were incubated for 1 h with PBS containing 1% normal sheep serum (NSS-PBS) and washed three times as described above. Thereafter, 75 ,ul of the saliva samples, diluted 1:10,000 in NSS-PBS were incubated in duplicate on the anti-human IgA-coated plates for 2 to 3 h at 37°C. After being washed, horseradish peroxidase-conjugated anti-human IgA (Dako-Immunoglobulins a/s) diluted 1:10,000 in NSS-PBS containing 5% polyethylene glycol 4000 was added, and the plates were incubated for 1.5 h at 37°C. After a threefold wash, 75 ,ul of 1,2-phenylenediamine (3 mg/ml) in 0.1 M citrate buffer (pH 5.6) containing 0.02% H202 was added and incubated for 15 to (28). ELISA. Specific antibodies were assayed by using ELISA. The antigens were diluted in PBS for coupling onto polystyrene microtiter plates (Linbro). In the coupling solution, the optical density of the sonicated streptococcal suspensions was 1.0 at 500 nm (Beckman Acta CII spectrophotometer). The concentrations of tetanus toxoid, B. pertlussis suspension, and parotitis cell lysate protein were 9 ,ug/ml, 5 x 108 bacteria per ml, and 5 ,ug/ml, respectively. The coupling solution, 100 pA/well, was incubated overnight at 37°C. The plates were washed twice with NaCl-Tween and once with PBS. Thereafter, 120 RI of NSS-PBS was added into each well, incubated for 1 h at 37°C, and washed as previously described.
Six dilutions of each sample in NSS-PBS were pipetted in duplicate into the wells at 100 pA/well. Saliva samples were diluted from 1:20 on and serum samples from 1:60 on at threefold intervals. The dilutions were incubated for 4 h at 37°C. After being washed, 100 pA of alkaline phosphataseconjugated anti-human IgG or IgA (Orion Diagnostica) diluted 1:200 or 1:150, respectively, in NSS-PBS was added to each well. After 12 to 16 h at room temperature and after being washed, 100 pL of 1,2-nitrophenyl phosphate (Orion Diagnostica) in diethanolamine buffer (Orion Diagnostica) (pH 10.5) was added, and the plates were incubated at 37°C for 15 to 40 min. After termination of the reaction with 100 plA of 1.0 M NaOH, the absorbances of each well were measured at 405 nm with the Titertek Multiskan.
All the assays of the samples for a certain antibody class and specificity were performed at the same time. A blank absorbance obtained by substituting antibody sample with plain buffer was subtracted from all absorbances.
Interpretation of ELISA results. The dose-response curves of each sample in ELISA were subjected to a curve-fitting procedure (26) . For each sample this gives two parameters which indicate in arbitrary units how much of the sample antibodies can bind either in antibody or antigen excess. These parameters have been shown to correlate separately with the amounts of high-avidity and total antigen-specific antibodies (25, 26) and are thus estimates of high-avidity antibodies and total specific antibodies.
Statistics. The means were compared by the Student t test. In addition, the results from the assays of specific salivary antibodies were subjected to an analysis of covariance in which the total salivary immunoglobulin concentrations of each subject were taken as covariates. The correlation between antibodies and the number of carious lesions was studied by Spearman's rank correlation analysis. RESULTS
The total IgA and IgG concentrations in saliva and serum of the two groups of subjects are presented in Table 1 . In serum immunoglobulins, there were no differences between the groups. However, the saliva of subjects in the HCS group contained more IgA than that of subjects in the LCS group, P = 0.05. With IgG, there was a similar tendency, but no statistical significance. Figure 1 1:1,620, 1:4,860) the difference was reversed. The doseresponse curves differed in shape, and this difference was taken into account by computing the estimates for highavidity antibodies and total specific antibodies.
The results from assays of serum high-avidity antibodies are shown in Table 2 . The only significant difference between the antibodies against the five antigens was that the HCS group had more high-avidity IgG antibodies against tetanus toxoid than the LCS group. Table 3 shows the amounts of serum total antigen-specific antibodies. There is only one significant difference; the LCS group had more high-avidity IgA antibodies against parotitis virus antigen than the HCS group.
In saliva ( Tables 4 and  5 . After the analysis of covariance, no difference in highavidity antibodies against the S. mutans strains was detected. There were significant differences between the groups in high-avidity IgG antibodies against B. pertussis and highavidity IgA antibodies against tetanus toxoid ( Table 4 ).
The LCS group had more total specific salivary IgA antibodies against S. mutans KlR and 10449 and IgG antibodies against S. mutans KlR than the HCS group, and these differences also remained after the analysis of covariance (Table 5 ). These antibodies did not correlate significantly to the number of carious lesions in the whole material (Spearman's correlation coefficients, -0.333, 0.210, and -0.225, respectively). No significant differences in antibodies against the unrelated antigens were noticeable after the analysis of covariance.
DISCUSSION
Most of the studies have revealed a negative correlation between decayed, missing, or filled score and serum anti-S. mutans antibodies, thus suggesting a protective role for these antibodies (5-7, 16, 21) . Serum antibody titers against S. mutans are higher in caries-active individuals than in individuals with low caries activity (15, 24) . Serum antibodies against S. mutans decrease after treatment of caries (5). In the present study, the HCS group contained subjects with many dentine lesions, and these subjects might have more antibodies than they would have without these lesions.
The HCS group had more IgA in whole saliva than the LCS group. Several investigators have found more IgA in the saliva of caries-resistant subjects than in that of cariesprone subjects (11, 19, 21, 30, 34) , but in some studies there were no significant differences (32, 35, 37 On the basis of the different shapes of the dose-response curves, the results are interpreted so that the HCS group had more high-avidity and less total specific antibodies against S. mutans than the LCS group. When the total immunoglobulin concentrations were taken as covariates, it was revealed that the differences in high-avidity antibodies against S. mutans were due to differences in total salivary immunoglobulin concentrations. The analysis of covariance gave significant differences in high-avidity antibodies against tetanus toxoid and B. pertussis, but on the other hand, these antibody estimates did not clearly differ without the analysis of covariance.
There was both an absolute and a relative difference in the amount of total specific salivary IgA antibodies against S. mutans KlR and 10449 and the amount of IgG antibodies against strain KlR between the LCS and HCS groups. This indicates a protective role for IgA and possibly IgG antibodies in whole saliva against S. mutans. The gingival bleeding indices of the HCS and LCS groups, however, differed from each other, and this differing degree of local inflammation might affect salivary antibodies (2) . The large amount of bacteria in the saliva of the individuals in the HCS group might also absorb antibodies to a larger extent than the saliva of those in the LCS group. Further, the current caries status of the groups differed from each other. However, no signifi- cant correlation was observed between the above-mentioned salivary antibodies and the individual number of carious lesions.
The HCS group had a lower level of total specific antibodies against S. miutans than the LCS group, but on the other hand, the HCS group had more high-avidity antibodies when no comparison to the total salivary immunoglobulins was performed. This means that the HCS group had a greater proportion of high-avidity antibodies than the LCS group. This difference in the avidity distributions of the antibodies might reflect a more established state of immunization in the HCS than in the LCS group (36) , perhaps due to differences in the ecology of S. mutans or in the disease history of the groups.
We could not demonstrate significant differences in the estimates of serum high-avidity anti-S. mutans antibodies between the HCS and LCS groups. This suggests that differences between individual immunoreactivities against S. mutans are not due to differing B-cell repertoires. The differences could merely be due to the regulation of the magnitude of antibody production. Recently, T helper cells have been shown to have dose dependency in the response against S. mutans antigen, and this dependency is linked to HLA-DR antigen (20) . However, it should be remembered that the antigen in the present study was crude, containing an undefined number of antigenic determinants. Further studies should be performed with purified antigens, enabling an exact avidity (affinity) determination.
The present study suggests that antibodies in whole saliva have a role in the control of caries. In previous studies, this may have been unnoticed because of methodological difficulties in the measurement of salivary antibodies. Thus, measurement of secretory immunity deserves attention in the development of vaccination against dental caries.
